Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
IKT on Nasdaq
Sands Capital Life Sciences Pulse Fund II, L.P. - trading volume in the past year for Inhibikase Therapeutics, Inc.
Holdings reported by Sands Capital Life Sciences Pulse Fund II, L.P. for Inhibikase Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
13,018,965 |
$18,877,499 |
$1.45 |
21 Nov 2025 |
Direct |
|
|
Transactions reported by Sands Capital Life Sciences Pulse Fund II, L.P. for Inhibikase Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.